健帆生物：关于健帆转债恢复转股的提示性公告

Core Viewpoint - The announcement from Jianfan Bio indicates that the "Jianfan Convertible Bond" will resume conversion into shares starting from August 15, 2025, following the end of the repurchase application period [2] Company Summary - Jianfan Bio has officially communicated the resumption of share conversion for its convertible bonds, which is a significant event for bondholders [2]